GW 405833

TargetMol
Product Code: TAR-T7705
Supplier: TargetMol
CodeSizePrice
TAR-T7705-1mg1mg£98.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7705-2mg2mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7705-5mg5mg£135.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7705-1mL1 mL * 10 mM (in DMSO)£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7705-10mg10mg£168.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7705-25mg25mg£249.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7705-50mg50mg£349.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7705-100mg100mg£485.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
GW 405833 is an agonist of cannabinoid-2 (CB(2)) receptor-selective
CAS:
180002-83-9
Formula:
C23H24Cl2N2O3
Molecular Weight:
447.36
Pathway:
GPCR/G Protein
Purity:
0.9993
SMILES:
COc1ccc2n(C(=O)c3cccc(Cl)c3Cl)c(C)c(CCN3CCOCC3)c2c1
Target:
Cannabinoid Receptor

References

Huang Z , Wang H , Wang J , et al. Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca2+ oscillations in mouse pancreatic acinar cells[J]. Scientific Reports, 2016, 6(1):29757. Parlar A , Arslan S , Do?an, Muhammed, et al. The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress[J]. Experimental and Therapeutic Medicine, 2018. Li A L , Carey L M , Mackie K , et al. The cannabinoid CB 2 agonist GW405833 suppresses inflammatory and neuropathic pain through a CB 1 mechanism that is independent of CB 2 receptors in mice[J]. Journal of Pharmacology and Experimental Therapeutics, 2017, 362(2):jpet.117.241901.